$IPH (Innate Pharma) Price Analysis
Buy, Hold or Sell?

Let's analyze Innate Pharma together

I guess you are interested in Innate Pharma. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

• 📈 Technical Analysis (TA) – Innate Pharma’s Price Targets

I'm going to help you getting a better view of Innate Pharma. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

Get notifications about Innate Pharma

I send you an email if I find something interesting about Innate Pharma.

Name

Email address

Add Email Alert

Technical Analysis of Innate Pharma
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Innate Pharma. The general trend of Innate Pharma is BEARISH with 100.0% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Innate Pharma's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

1. Innate Pharma Price Targets

1.1 sr

---

Score

Let's take a look at the sr of Innate Pharma.

• The price is currently trading around a support level. This can be considered as a potential entry level.

3rd party ad SUPPORTERis ad-free.

2. Trend Indicators

2.1 Moving Averages

---

Score

Let's take a look at the Moving Averages of Innate Pharma.

• The SHORT shows weakening trend behaviour.
• Price action is trading under pressure relative to the SHORT.
• The SHORT is lagging behind the MEDIUM, indicating weaker trend alignment.
• The SHORT is lagging behind the INTER, indicating weaker trend alignment.
• The SHORT is lagging behind the LONG, indicating weaker trend alignment.
• The MEDIUM shows weakening trend behaviour.
• Price action is trading under pressure relative to the MEDIUM.
• The MEDIUM is lagging behind the INTER, indicating weaker trend alignment.
• The MEDIUM is lagging behind the LONG, indicating weaker trend alignment.
• The INTER shows weakening trend behaviour.
• Price action is trading under pressure relative to the INTER.
• The INTER is lagging behind the LONG, indicating weaker trend alignment.
• The LONG shows weakening trend behaviour.
• Price action is trading under pressure relative to the LONG.

Directionalities and relatives.

Moving Average	Trend	Price	vs. MEDIUM	vs. INTER	vs. LONG
SHORT
MEDIUM
INTER
LONG

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

2.2 Moving Average Convergence/Divergence (MACD)

---

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Innate Pharma.

• Momentum is leaning bearish. Selling pressure outweighs buying interest, indicating increased caution and reduced risk appetite among market participants.
• Overall momentum is negative. Market conditions reflect cautious sentiment, with sellers exerting more influence and limiting upside progress for Innate Pharma.
• Momentum is weakening. Bearish pressure is increasing as confidence fades and market participants shift toward defensive positioning.

2.3 Directional Movement Index (DMI)

---

Score

Let's take a look at the Directional Movement Index (DMI) of Innate Pharma.

• Directional bias favors sellers. Selling pressure dominates buying interest, reflecting cautious sentiment and increasing downside pressure.
• Directional bias leans bearish while trend strength is beginning to build, often seen during early stages of downside development.

2.4 Parabolic SAR

---

Score

Let's take a look at the Parabolic SAR of Innate Pharma.

• Price action is under pressure relative to the prevailing trend structure, which is commonly interpreted as a bearish market signal.

3rd party ad SUPPORTERis ad-free.

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

---

Score

Let's take a look at the Relative Strength Index (RSI) of Innate Pharma. The current phase is Continuation in bear market.

• Downtrend continues after a consolidation or pullback. Hold or add to short positions.
• Momentum is weakening as selling pressure becomes more pronounced.

3.2 Stochastic Oscillator

---

Score

Let's take a look at the Stochastic Oscillator of Innate Pharma. The current phase is Oversold in bear market.

• Momentum favors sellers, indicating reduced buying interest and growing downside pressure.
• Selling pressure appears exhausted, often seen near potential stabilization or rebound phases.
• Momentum is leaning bearish, with selling pressure outweighing buying interest and signaling increased short-term caution for Innate Pharma.
• Momentum is weakening as selling pressure increases and short-term sentiment deteriorates.

3.3 Commodity Channel Index (CCI)

---

Score

Let's take a look at the Commodity Channel Index (CCI) of Innate Pharma.

• Price action appears stretched to the downside, suggesting selling pressure may be exhausted and conditions could stabilize or rebound.

3.4 Chande Momentum Oscillator (CMO)

---

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Innate Pharma.

• Momentum is leaning negative, indicating cautious market conditions and increasing downside participation.

3.5 Williams %R

---

Score

Let's take a look at the Williams %R of Innate Pharma.

• Downward momentum appears stretched, suggesting selling pressure may be exhausted and conditions could stabilize or rebound.

3rd party ad SUPPORTERis ad-free.

4. Volatility Indicators

4.1 Bollinger Bands

---

Score

Let's take a look at the Bollinger Bands of Innate Pharma.

4.2 Average True Range (ATR)

---

Score

Let's take a look at the Average True Range (ATR) of Innate Pharma.

3rd party ad SUPPORTERis ad-free.

5. Volume Indicators

5.1 On-Balance Volume (OBV)

---

Score

Let's take a look at the On-Balance Volume (OBV) of Innate Pharma.

5.2 Money Flow Index (MFI)

---

Score

Let's take a look at the Money Flow Index (MFI) of Innate Pharma.

• Money flow favors buyers, indicating constructive participation and supportive market conditions.

3rd party ad SUPPORTERis ad-free.

6. Summary

6.1. Notifications

Type	Notification	Date
Currently no notifications for Innate Pharma.

6.3. Candlestick Patterns

Date	Candlestick Pattern